Cargando…
Automated quantitative multiplex immunofluorescence in situ imaging identifies phospho-S6 and phospho-PRAS40 as predictive protein biomarkers for prostate cancer lethality
BACKGROUND: We have witnessed significant progress in gene-based approaches to cancer prognostication, promising early intervention for high-risk patients and avoidance of overtreatment for low-risk patients. However, there has been less advancement in protein-based approaches, even though perturbed...
Autores principales: | Shipitsin, Michail, Small, Clayton, Giladi, Eldar, Siddiqui, Summar, Choudhury, Sibgat, Hussain, Sadiq, Huang, Yi E, Chang, Hua, Rimm, David L, Berman, David M, Nifong, Thomas P, Blume-Jensen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114438/ https://www.ncbi.nlm.nih.gov/pubmed/25075204 http://dx.doi.org/10.1186/1477-5956-12-40 |
Ejemplares similares
-
Pre-analytic variables and phospho-specific antibodies: the Achilles heel of immunohistochemistry
por: Siddiqui, Summar, et al.
Publicado: (2010) -
Prognostic role of phospho-PRAS40 (Thr246) expression in gastric cancer
por: Lu, Yi-Zhuo, et al.
Publicado: (2013) -
Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
por: Shipitsin, M, et al.
Publicado: (2014) -
Phospho-PRAS40(Thr246) predicts trastuzumab response in patients with HER2-positive metastatic breast cancer
por: YUAN, KAI, et al.
Publicado: (2015) -
Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
por: Kitano, Haruhisa, et al.
Publicado: (2014)